BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27530852)

  • 1. Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Aung HL; Tun T; Moradigaravand D; Köser CU; Nyunt WW; Aung ST; Lwin T; Thinn KK; Crump JA; Parkhill J; Peacock SJ; Cook GM; Hill PC
    J Glob Antimicrob Resist; 2016 Sep; 6():113-117. PubMed ID: 27530852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
    Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Swe TL; Lwin T; Htwe MM; Kim KJ; Lee JS; Kim CK; Cho SN; Song SD; Chang CL
    Ann Lab Med; 2015 Sep; 35(5):494-9. PubMed ID: 26206685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
    Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S
    BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
    Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
    Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mai TQ; Martinez E; Menon R; Van Anh NT; Hien NT; Marais BJ; Sintchenko V
    Am J Trop Med Hyg; 2018 Dec; 99(6):1397-1406. PubMed ID: 30382014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
    Aye KS; Nakajima C; Yamaguchi T; Win MM; Shwe MM; Win AA; Lwin T; Nyunt WW; Ti T; Suzuki Y
    J Infect Chemother; 2016 Mar; 22(3):174-9. PubMed ID: 26806152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.
    Basu I; Bower JE; Roberts SA; Henderson G; Aung HL; Cook G; Lowe O; Newton S
    N Z Med J; 2018 Dec; 131(1487):15-22. PubMed ID: 30543607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mutations conferring streptomycin resistance to multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Thida Oo NA; San LL; Thapa J; Aye KS; Aung WW; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2018 Jul; 111():8-13. PubMed ID: 30029920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Htwe MM; Win SM; Aye KT; Mon AS; Aung ST; Chang CL; Lee JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263056
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar.
    Chang Y; Kim S; Kim Y; Ei PW; Hwang D; Lee J; Chang CL; Lee H
    Ann Lab Med; 2020 Mar; 40(2):142-147. PubMed ID: 31650730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.